Strong performance expected to deliver revenue and adjusted EBITDA growth in the range of 15% to 20% 21 December 2018 – Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, notes the recent movement in its share price...
09 November 2018 – Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018. For those shareholders who have previously...
7 November 2018 – Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed. The proxy voting results are included...
6 November 2018 – Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 1pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:...
Schedule 6, Block Admission Period to 15 October 2018 This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the...
The Company’s 2018 Annual Report has been posted to shareholders together with the Notice of Annual General Meeting and the associated form of proxy. The Company’s AGM will be held at the offices of Peel Hunt LLP, 120 London Wall, London, EC2Y 5ET, UK, on 6 November...
